0
0
A new India–UK initiative is seeking to move artificial intelligence (AI) in healthcare from buzzword to bedside, with a strong emphasis on ethics, safety and shared learning between London and Kolkata. At the Indi Setu Thought Leadership Summit in London, clinicians, technologists and policy voices argued that AI must enhance—not replace—human clinical judgment, while new collaborations aim to support socially impactful health startups in both countries.
What the Indi Setu Summit Set Out to Do
Hosted under the Global Collaboration Forum (GCF), founded by Kolkata-based urologist Dr Amit Ghose, the Indi Setu summit was framed as an “intellectual and cultural bridge” linking Indian and UK innovators in health, sustainability and education. The London meeting brought together cardiologists, AI leads, academics and industry experts to explore how AI can improve diagnosis, workflows and access to care without eroding trust or compassion.
A key outcome is the decision to grow Indi Setu from a single summit into a continuing platform connecting London’s mature digital health ecosystem with emerging hubs such as Kolkata through mentorship, funding and joint programmes. In October, GCF signed a Memorandum of Understanding with IIM Calcutta Innovation Park to support socially impactful startups in healthcare, sustainability and clean technology via mentoring, demo days and investor connections.
Key Messages on AI in Healthcare
Speakers repeatedly stressed that AI tools must lead to “meaningful clinical outcomes,” rather than novelty, and be firmly guided by clinicians. London-based cardiologist Dr Arjun K. Ghosh and IBM healthcare AI leader Dr Avi Mehra highlighted that patients ultimately want clinical care, not a machine’s answer, and that intelligent systems should be woven into workflows so doctors spend more time with patients, not paperwork.
This emphasis aligns with global guidance from the World Health Organization, which notes that AI can strengthen diagnosis, treatment and person‑centred care, particularly in settings with shortages of specialists, but warns of risks such as biased data, privacy threats and cybersecurity vulnerabilities. WHO urges regulators and developers to prioritise transparency, robust validation, data quality and clear “intended use” labelling for AI tools, especially when deployed in real‑world clinical environments.
Why London–Kolkata Collaboration Matters
The Indi Setu platform positions London’s National Health Service (NHS) experience with digital health and AI as a learning partner for Indian health systems that are scaling technology at speed. NHS England has described AI’s potential to support imaging, triage and risk prediction, while underscoring that robust evidence, integration into clinical workflows and ongoing safety monitoring are essential for any deployment.
In the UK, regulators are experimenting with “regulatory sandboxes” to test AI-as-medical-device systems using real products and data, aiming to refine safety, performance monitoring and update processes before wide rollout. These experiences could inform Indian regulators and health systems as they consider how to evaluate AI solutions emerging from innovation hubs supported by Indi Setu and partners like IIM Calcutta Innovation Park.
Beyond Algorithms: Training, Equity and Community
For Dr Ghose and fellow organisers, the initiative is not just about high‑end technology but also about training nurses, technicians and doctors to work confidently with AI tools and expanding access to quality care, especially for underserved communities in and around Kolkata. Their stated ambition is to develop AI‑enabled institutions and services that reflect the “Xaverian” ethos of service and humility, with a focus on people who need care the most.
Planned follow‑up activities include the next Indi Setu edition in 2025, where themes are expected to deepen around AI ethics, climate resilience and cross‑border health models, alongside “Planet Pitch,” a stage for Indian startups to showcase sustainability‑driven innovations to international investors. By framing AI alongside climate and equity, the summit places digital health within a broader public‑interest agenda rather than a purely commercial race.
How This Could Affect Patients and Clinicians
If Indi Setu’s vision is realised, patients in India and the UK could benefit from AI tools that are co‑designed by clinicians, tested in diverse settings and evaluated against shared safety standards. Examples might include more accurate imaging support in district hospitals, decision‑support tools for primary care, or algorithm‑assisted triage that shortens waiting times—provided systems are transparent, validated and carefully monitored.
For clinicians, responsible AI could reduce administrative burden, highlight high‑risk cases and support earlier detection, but experts caution that over‑reliance on algorithms, poorly curated data or opaque “black box” models could undermine clinical reasoning and patient trust. Person‑first language and shared decision‑making remain critical: digital tools should help clinicians explain options more clearly, not replace conversations.
Risks, Limitations and Open Questions
Speakers at Indi Setu and global health bodies alike acknowledge that AI is not a quick fix for workforce shortages, fragmented data systems or structural inequities in care. Many AI models are trained on data that may not reflect diverse populations, raising the risk that tools could perform worse for certain groups unless they are carefully validated and continuously updated.
There are also policy and governance gaps: questions remain about liability when AI makes or contributes to an error, how to manage continuous model updates, and how to ensure informed consent and data protection when large datasets cross borders. Experts stress that collaboration between regulators, clinicians, patients, technologists and industry will be crucial so that safety, fairness and accountability keep pace with innovation.
What Readers Should Keep in Mind
For healthcare professionals, the Indi Setu story underlines the importance of engaging early with AI projects—asking about evidence, validation in relevant populations, workflow impact and governance rather than simply adopting new tools because they are available. For health‑conscious readers, it reinforces that AI may increasingly support behind‑the‑scenes decisions in imaging, triage or risk scoring, but that individual care should still be grounded in face‑to‑face clinical assessment and open dialogue with qualified practitioners.
As Indi Setu evolves from summit to “network of networks,” its influence will depend on whether it can turn high‑level conversations into measurable changes in safety, access and patient experience in both London and Kolkata. The central message emerging from London is that the future of AI in healthcare is not simply artificial or automated—it is collaborative, clinician‑led and accountable to the communities it intends to serve.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
Summit and initiative sources
-
“From London to Kolkata: Indi Setu Summit Charts a New Future for AI, Healthcare, and Collaboration.” ETHealthWorld – Economic Times Health, 26 Nov 2025
